Lepu Medical Technology (Beijing) stock | Price target for 2026, price & analyst rating

Lepu Medical Technol...

SZSE:300003

¥ 16,24

+ ¥0,57 (3,64%)

16,24 ¥

+¥0,57 (3,64%)

End-of-day quote: 03/27/2026

Lepu Medical Technology (Beijing) Stock Value

The analyst rating for SZSE:300003 is currently Outperform.

Outperform

Lepu Medical Technology (Beijing) Company Info

EPS Growth 5Y

-37,77%

Market Cap

¥29,33 B

Long-Term Debt

¥3,63 B

Quarterly earnings

04/23/2026

Dividend

¥0,28

Dividend Yield

1,72%

Founded

1999

Industry

Health Care

Country

China

Website

Lepu Medical Technology (Beijing)

ISIN Number

CNE100000H44

Website

http://www.lepumedical.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

¥20,29

24.94%

Last Update: 03/28/2026

Analysts: 5

Highest Price Target ¥24,00

Average Price Target ¥20,29

Lowest Price Target ¥16,90

In the last five quarters, Lepu Medical Technology (Beijing)’s Price Target has risen from ¥20,67 to ¥25,02 - a 21,04% increase. Seven analysts predict that Lepu Medical Technology (Beijing)’s share price will increase in the coming year, reaching ¥20,29. This would represent an increase of 24,94%.

Top growth stocks in the health care sector (5Y.)

What does Lepu Medical Technology (Beijing) do?

Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical Technology) is a player in the medical devices and healthcare technology sector, heavily involved in the research, development, and manufacturing of various medical devices. The company has established itself as a research and development-driven enterprise, with a strong commitment to innovation in medical technology. By adhering to the practice of actively pushing forward new generations of research while concurrently managing production...

Business Segments

Lepu Medical Technology operates through various business segments, each focusing on specific areas of medical technology and healthcare services. The primary segments include:

Medical Devices Segment

This segment includes the research, development, and manufacturing of a wide array of medical devices, which are essential for modern healthcare delivery. The company has developed numerous innovative devices tailored for specific medical needs, improving patient care outcomes.

Pharmaceutical Segment

This segment involves in the development and distribution of pharmaceuticals. By engaging in pharmacological innovations, the company aims to enhance treatment options and provide effective solutions to various health conditions.

Medical Services and Health Management Segment

This segment focuses on providing comprehensive healthcare services and management, integrating the usage of advanced medical technologies with patient care. The company is dedicated to streamlining healthcare delivery and improving patient access to medical services.

Digital Health Solutions

This segment ventures into digital health, which encompasses telemedicine solutions and healthcare management platforms to create a more efficient healthcare ecosystem.

Business Strategy

The company’s overarching strategy hinges on continuous innovation and R&D, allowing it to expand its product portfolio and maintain a competitive edge in the medical technology sector. Its commitment to Research and Development significantly shapes its strategic initiatives. By placing innovation at the forefront, the company ensures its products meet the evolving demands of healthcare providers and patients alike.

To strengthen its market position, the company emphasizes the importance of regulatory compliance and quality assurance across all stages of product development. Through proactive engagement with regulatory bodies, it aims to streamline the approval process for its medical devices, thereby enhancing market readiness. The company also aims to leverage partnerships and collaborations within the healthcare ecosystem to bolster research and expand market reach, engaging in meaningful collaborations that drive mutual growth.

With a customer-centric approach, the company targets key market segments that can benefit from its advanced medical technologies and services. By closely monitoring market trends and consumer needs, it positions itself to offer tailored solutions that align with healthcare providers' goals, ultimately improving patient outcomes. The company commits to sustainable growth through strategic investments in emerging technologies and expansion into new geographical markets, thus broadening its global footprint.

Products and Services

The company proudly offers a comprehensive suite of products and services that cater to diverse medical needs. The expansive range of offerings includes:

Cardiovascular Devices: The company specializes in a variety of cardiovascular equipment, including occludes and stents, designed to support patients with cardiovascular diseases.

Diagnostics Solutions: A key aspect of its offerings, the diagnostics solutions encompass a range of medical imaging and testing devices that facilitate effective disease detection and management.

Operating Room Equipment: The company provides essential equipment for surgical environments, ensuring healthcare professionals have access to advanced medical tools needed for successful procedures.

Pharmaceuticals: The pharmaceutical arm contributes important medications that target specific health conditions, complementing its device offerings with therapeutic solutions.

Digital Health Technologies: The incorporation of digital health solutions like telehealth platforms enables the company to offer comprehensive health management services, merging technology with patient care.

Healthcare Management Services: With a focus on health management, the company provides various services that improve healthcare delivery efficiency, promoting better overall patient care.

Geographical Markets Served

Lepu Medical Technology operates in multiple geographical markets, leveraging its expertise and product offerings to address global healthcare challenges. The company maintains a significant presence in China, where most of its operations and sales activities are concentrated. However, it also actively pursues opportunities in international markets, expanding its reach into regions such as Europe and North America.

Customers

Lepu Medical Technology serves a diverse customer base, which includes hospitals, clinics, and healthcare providers across various specialties in both domestic and international markets.

Sales and Marketing

Lepu Medical Technology employs a multifaceted approach to sales and marketing, encompassing direct-to-hospital sales, partnerships with distributors, and participation in healthcare industry conferences and events. Through these channels, the company effectively communicates the value of its products and services to healthcare providers while establishing a robust market presence.

The marketing strategy focuses on highlighting the company’s innovative capabilities and proven track record in medical technology development. By leveraging digital marketing platforms, the company reaches a broader audience and engages directly with healthcare professionals, providing them with comprehensive information about product offerings.

The distribution channels include both direct sales teams and an extensive network of distributors, ensuring efficient product delivery and support services. This enables Lepu Medical Technology to maintain close relationships with its customers and respond swiftly to changing market demands.

History

Lepu Medical Technology (Beijing) Co., Ltd. was founded in 1999.

Lepu Medical Technology (Beijing) Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Medical Technology:** 45% **Pharmaceuticals:** 30% **Diagnostics:** 25% **Top 3 Markets:** **China:** 60% **USA:** 20% **Europe:** 15% Lepu Medical Technology generates the majority of its revenue from medical technology, followed by pharmaceuticals and diagnostics. The Chinese mar...

At which locations are the company’s products manufactured?

**Production Sites:** Mainly in China Lepu Medical Technology (Beijing) Co., Ltd. produces the majority of its products in China. The company has several production facilities in the country that specialize in the manufacturing of medical devices and equipment. This strategic placement enables Lepu...

What strategy does Lepu Medical Technology (Beijing) pursue for future growth?

**Revenue Growth:** Estimated at 10-12% annually (2025) **R&D Investments:** Increased by approximately 20% (2025) Lepu Medical Technology pursues a growth strategy that is heavily focused on research and development (R&D). The company has significantly increased its investments in R&D...

Which raw materials are imported and from which countries?

**Main raw materials:** Medical plastics, stainless steel, silicone, electronic components **Main importing countries:** USA, Germany, Japan Lepu Medical Technology (Beijing) Co., Ltd. imports a variety of raw materials and materials necessary for the production of their medical products. These in...

How strong is the company’s competitive advantage?

**Market share:** 12% in the Chinese medical technology market (2024) **Research and development ratio:** 8.5% of revenue (2024) **Patents:** Over 500 active patents worldwide (2025) Lepu Medical Technology has a significant competitive advantage in the field of medical technology, especially in...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 35% (estimated, 2025) **Insider Purchases:** No significant purchases reported (2025) **Insider Sales:** Moderate sales reported (2025) The institutional investor share in Lepu Medical Technology is estimated to be around 35%. This indicates a solid interest fr...

What percentage market share does Lepu Medical Technology (Beijing) have?

**Market share of Lepu Medical:** 8% (2025, estimated) **Major competitors and their market shares:** 1. **Medtronic plc:** 15% 2. **Johnson & Johnson:** 12% 3. **Boston Scientific Corporation:** 10% 4. **Abbott Laboratories:** 9% 5. **Lepu Medical Technology:** 8% 6. **Stryker Cor...

Is Lepu Medical Technology (Beijing) stock currently a good investment?

**Revenue Growth:** 18% (2024) **R&D Expenses:** 12% of revenue (2024) **Market Share in Cardiology:** 20% (2024) Lepu Medical Technology recorded strong revenue growth of 18% in 2024, driven by increased demand for their medical devices and services. The company continuously invests in researc...

Does Lepu Medical Technology (Beijing) pay a dividend – and how reliable is the payout?

**Dividend payment:** Yes, Lepu Medical Technology pays a dividend. **Dividend yield:** Approximately 1.5% (estimated for 2025 based on historical data). **Dividend history:** Regular payouts in recent years. Lepu Medical Technology has regularly distributed dividends in recent years, indicatin...

New support ticket

Explore

Lepu Medical Technology (Beijing) Stock Value

Lepu Medical Technology (Beijing) Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Lepu Medical Technology (Beijing) do?

Lepu Medical Technology (Beijing) Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Lepu Medical Technology (Beijing) Stock Value

Lepu Medical Technology (Beijing) Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Lepu Medical Technology (Beijing) do?

Lepu Medical Technology (Beijing) Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.